'Science. not sensationalism', J&J moves to weather the storm on powder row

Johnson & Johnson on Monday scrambled to contain fallout from a Reuters report that the healthcare conglomerate knew for decades that cancer-causing asbestos lurked in its Baby Powder, taking out full-page newspaper ads defending its product and practices, and readying its chief executive for his first television interview since investors erased tens of billions of dollars from the company's market value. J&J shares fell nearly 3 per cent Monday, closing at $129.

14 in New York Stock Exchange trading. That drop was on top of the.

This article is no longer available in our repository.

There could be multiple reasons for this.